Kenneth Burhop
Director/Board Member chez OptMed, Inc.
Profil
Actuellement, Kenneth E. Burhop occupe le poste de directeur scientifique et vice-président d'Integra LifeSciences Holdings Corp. Il a précédemment occupé le poste de directeur scientifique de Sangart, Inc. et de vice-président de Baxter International, Inc. et directeur scientifique de Baxter Healthcare Corp. (une filiale de Baxter International, Inc.). Le Dr Burhop a obtenu un doctorat et un diplôme d'études supérieures de l'Université du Wisconsin et un diplôme de premier cycle de l'Université du Wisconsin-Milwaukee.
Postes actifs de Kenneth Burhop
| Sociétés | Poste | Début |
|---|---|---|
OptMed, Inc.
 OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Director/Board Member | 01/05/2022 |
Anciens postes connus de Kenneth Burhop
| Sociétés | Poste | Fin |
|---|---|---|
Sangart, Inc.
 Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/10/2013 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Chief Tech/Sci/R&D Officer | - |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Chief Tech/Sci/R&D Officer | - |
Formation de Kenneth Burhop
| University of Wisconsin | Doctorate Degree |
| University of Wisconsin-Milwaukee | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Health Technology |
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
